Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Dow
Cerilliant
US Department of Justice
McKinsey
Fuji
Citi
Baxter

Generated: September 20, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DESIPRAMINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Desipramine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed Yale University Phase 2 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000212 IV Cocaine Abuse: A Laboratory Model - 1 Completed Columbia University Phase 2 The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000212 IV Cocaine Abuse: A Laboratory Model - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000212 IV Cocaine Abuse: A Laboratory Model - 1 Completed New York State Psychiatric Institute Phase 2 The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000217 Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
NCT00000217 Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed VA Office of Research and Development Phase 2 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Desipramine Hydrochloride

Condition Name

Condition Name for Desipramine Hydrochloride
Intervention Trials
Depression 12
Substance-Related Disorders 6
Cocaine-Related Disorders 5
Irritable Bowel Syndrome 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Desipramine Hydrochloride
Intervention Trials
Depression 11
Depressive Disorder 9
Disease 6
Substance-Related Disorders 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Desipramine Hydrochloride

Trials by Country

Trials by Country for Desipramine Hydrochloride
Location Trials
United States 51
Canada 3
Switzerland 3
France 2
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Desipramine Hydrochloride
Location Trials
California 8
New York 7
Massachusetts 5
Missouri 4
Connecticut 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Desipramine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Desipramine Hydrochloride
Clinical Trial Phase Trials
Phase 4 11
Phase 3 8
Phase 2 18
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Desipramine Hydrochloride
Clinical Trial Phase Trials
Completed 45
Unknown status 5
Recruiting 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Desipramine Hydrochloride

Sponsor Name

Sponsor Name for Desipramine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 9
VA Office of Research and Development 7
Sandoz 4
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Desipramine Hydrochloride
Sponsor Trials
Other 58
NIH 18
Industry 17
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Daiichi Sankyo
Cerilliant
US Army
Harvard Business School
Boehringer Ingelheim
Fuji
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.